About US
Contact us
-
TC BioPharm collaborates with Medinet for new cancer immuno-cell therapyScotland-based biotechnology firm TC BioPharm (TCB) has entered into a strategic collaboration with Medinet, a Japanese immuno-cell therapy company, for developing a new treatment for different types2014/3/17
-
Upsher-Smith's antiepileptic drug Qudexy XR gets FDA approvalUpsher-Smith Laboratories (Upsher-Smith) has secured approval from the US Food and Drug Administration (FDA) for Qudexy XR (topiramate) extended-release capsules, indicated as initial monotherapy in p2014/3/14
-
AstraZeneca introduces combination drug Xigduo in UK for type 2 diabetesAstraZeneca has launched its twice-daily tablet Xigduo (dapagliflozin and metformin hydrochloride in 5mg/850mg and 5mg/1000mg tablets) in the UK to treat patients with type 2 diabetes. Xigduo is the2014/3/14
-
Activate your visitor badge today6-8 May 2014Palexpo, Geneva, Switzerland ACTIVATE YOUR VISITOR BADGE FOR VITAFOODS EUROPE 20142014/3/13
-
Remarkable Keynote Speakers - ExcipientFest Americas 2014Check our Educational Summary View this email in your browser. APRIL 28-30, 2014 Raleigh Convention CenterRaleigh - NCwww.excipientfest.com2014/3/13
-
Bayer announces approval of Adempas for hypertension treatmentBayer Canada has announced that Adempas (riociguat tablets) has now been approved for treating patients with pulmonary arterial hypertension (PAH). Bayer claims that Adempas, a soluble guanylate cycl2014/3/12
-
Novartis' Urticaria drug Xolair obtains EU approvalNovartis has received approval from the European Commission (EC) to use Xolair (omalizumab) as an add-on therapy to treat chronic spontaneous urticaria (CSU) in adult and adolescent patients 12 years2014/3/12
-
Curie-Cancer and DNA Therapeutics partner to combat cancerCurie-Cancer and French biopharmaceutical firm DNA Therapeutics have renewed their partnership to provide a new class of therapeutic cancer products to patients, including those resistant to conventio2014/3/11
-
Endo obtains FDA approval for Aveed injectable replacement therapy for hypogonadismEndo Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its new prescription medicine Aveed (testosterone undecanoate) injection to treat adult men with hypogonad2014/3/11
-
Tracon and Santen partner to develop TRC105 in ophthalmologyUS-based Tracon Pharmaceuticals has entered into an exclusive agreement with Japan-based Santen Pharmaceutical for the development and global commercialisation of its anti-endoglin antibodies, includi2014/3/10